PortfoliosLab logoPortfoliosLab logo
NEM vs. ANAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEM vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Newmont Corporation (NEM) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEM achieves a -5.74% return, which is significantly lower than ANAB's 65.10% return.


NEM

1D
-2.14%
1M
0.44%
6M
-16.23%
YTD
-5.74%
1Y
52.51%
3Y*
33.89%
5Y*
11.52%
10Y*
10.07%
ALL TIME*
4.83%

ANAB

1D
-3.05%
1M
-18.45%
6M
68.83%
YTD
65.10%
1Y
226.03%
3Y*
57.31%
5Y*
28.35%
10Y*
ALL TIME*
18.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$39.97M$46.98M$40.05M
$671.95M$683.19M$803.32M

NEM vs. ANAB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEM
Newmont Corporation
-5.74%172.82%-7.83%-8.76%-20.77%7.40%40.28%30.52%-6.15%8.11%
ANAB
AnaptysBio, Inc.
65.10%266.16%-38.19%-30.88%-10.82%61.63%32.31%-74.53%-36.67%529.50%

Correlation

The correlation between NEM and ANAB is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.10

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.09

Correlation (All Time)
Calculated using the full available price history since Jan 26, 2017

0.07

Fundamentals

Market Cap

NEM:

$98.74B

ANAB:

$2.30B

EPS

NEM:

$7.88

ANAB:

-$0.90

PS Ratio

NEM:

5.34

ANAB:

6.82

PB Ratio

NEM:

2.82

ANAB:

120.10

Total Revenue (TTM)

NEM:

$19.13B

ANAB:

$232.39M

Gross Profit (TTM)

NEM:

$10.94B

ANAB:

$245.59M

EBITDA (TTM)

NEM:

$14.81B

ANAB:

$52.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEM vs. ANAB — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NEM
NEM Risk / Return Rank: 7474
Overall Rank
NEM Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
NEM Sortino Ratio Rank: 7272
Sortino Ratio Rank
NEM Omega Ratio Rank: 7373
Omega Ratio Rank
NEM Calmar Ratio Rank: 7575
Calmar Ratio Rank
NEM Martin Ratio Rank: 7474
Martin Ratio Rank

ANAB
ANAB Risk / Return Rank: 9696
Overall Rank
ANAB Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ANAB Sortino Ratio Rank: 9494
Sortino Ratio Rank
ANAB Omega Ratio Rank: 9494
Omega Ratio Rank
ANAB Calmar Ratio Rank: 9898
Calmar Ratio Rank
ANAB Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NEM vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NEMANABDifference
Sharpe ratioReturn per unit of total volatility

-1.98

Sortino ratioReturn per unit of downside risk

-1.79

Omega ratioGain probability vs. loss probability

1.21

1.45

-0.24

Calmar ratioReturn relative to maximum drawdown

1.64

8.14

-6.50

Martin ratioReturn relative to average drawdown

3.61

19.84

-16.22

NEM vs. ANAB - Sharpe Ratio Comparison

The current NEM Sharpe Ratio is 1.11, which is lower than the ANAB Sharpe Ratio of 3.10. The chart below compares the historical Sharpe Ratios of NEM and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NEM vs. ANAB - Drawdown Comparison

The maximum NEM drawdown since its inception was -81.30%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for NEM and ANAB.


Loading charts...

Drawdown Indicators


NEMANABDifference

Max Drawdown

Largest peak-to-trough decline

-81.30%

-92.08%

+10.78%

Max Drawdown (1Y)

Largest decline over 1 year

-32.10%

-27.96%

-4.14%

Max Drawdown (3Y)

Largest decline over 3 years

-36.57%

-69.32%

+32.75%

Max Drawdown (5Y)

Largest decline over 5 years

-62.40%

-69.32%

+6.92%

Max Drawdown (10Y)

Largest decline over 10 years

-62.40%

Current Drawdown

Current decline from peak

-28.67%

-37.74%

+9.07%

Average Drawdown

Average peak-to-trough decline

-41.33%

-64.17%

+22.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.57%

11.45%

+3.12%

Volatility

NEM vs. ANAB - Volatility Comparison

The current volatility for Newmont Corporation (NEM) is 11.58%, while AnaptysBio, Inc. (ANAB) has a volatility of 27.46%. This indicates that NEM experiences smaller price fluctuations and is considered to be less risky than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEMANABDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.58%

27.46%

-15.88%

Volatility (6M)

Calculated over the trailing 6-month period

37.40%

51.26%

-13.86%

Volatility (1Y)

Calculated over the trailing 1-year period

47.45%

73.55%

-26.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.35%

66.36%

-28.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.74%

75.51%

-39.77%

Dividends

NEM vs. ANAB - Dividend Comparison

NEM's dividend yield for the trailing twelve months is around 1.09%, while ANAB has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ANAB
AnaptysBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NEM
Newmont Corporation
1.09%1.00%2.69%3.87%4.66%3.55%1.74%3.31%1.62%0.67%0.37%0.56%

Financials

NEM vs. ANAB - Financials Comparison

This section allows you to compare key financial metrics between Newmont Corporation and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


NEM and ANAB have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANAB has higher volatility (27.46%) compared to NEM (11.58%). In terms of maximum drawdown, NEM dropped -81.30% vs ANAB's -92.08%.

ANAB currently has the higher Sharpe Ratio (3.10 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEM and ANAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer